|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| REVENUE: | |||||
| Material sales | |||||
| Royalty and license fees | |||||
| Contract research services | |||||
| Total revenue | |||||
| COST OF SALES | |||||
| Gross margin | |||||
| OPERATING EXPENSES: | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Amortization of acquired technology and other intangible assets | |||||
| Patent costs | |||||
| Royalty and license expense | |||||
| Total operating expenses | |||||
| OPERATING INCOME | |||||
| Interest income, net | |||||
| Other and other income, net | |||||
| Interest and other income, net | |||||
| Income before income taxes | |||||
| INCOME TAX EXPENSE | |||||
| NET INCOME | |||||
| NET INCOME PER COMMON SHARE: | |||||
| BASIC | |||||
| DILUTED | |||||
| WEIGHTED AVERAGE SHARES USED IN COMPUTING NET INCOME PER COMMON SHARE: | |||||
| BASIC | |||||
| DILUTED | |||||
| CASH DIVIDEND DECLARED PER COMMON SHARE |
Loading...